LeMaitre Vascular Inc (LMAT)

92.63 +1.25 (+1.37%) USD  |  NASDAQ  |  Dec 24, 16:00
More

LeMaitre Vascular Research and Development Expense (Quarterly): 3.656M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for LMAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Baxter International Inc 129.00M
Insulet Corp 54.90M
Globus Medical Inc 35.38M
ResMed Inc 79.52M
Perspective Therapeutics Inc 12.03M